Clinical Research

heart ice cool cold freezing frozen

Cardiologists are first in world to use new cooling device to terminate AFib during surgery

Patients often develop AFib during cardiac surgery, leading to longer hospital stays, additional healthcare costs and a higher risk of mortality. Cooling the oblique sinus of the patient's heart as soon as AFib starts to develop may represent a new way to stop the problem in its tracks. 

Dan Budoff explains use of CCTA to track coronary disease plaque progression

CCTA shows colchicine's impact on atherosclerosis progression

Matthew Budoff, MD, detailed new data highlighting CCTA's value when it comes to tracking the progression of coronary atherosclerosis.

MRI biomarkers could signal early onset of Parkinson's.

Experts identify MRI biomarkers that could signal the early onset of Parkinson's

Using one of the most powerful MRI scanners to date, researchers believe they have identified subtle neural changes in the brain that precede Parkinson’s disease. 

PET imaging reveals long-term heart and lung damage from COVID-19

New data highlight the long-lasting effects of the coronavirus, revealing changes that are not detectable by standard medical assessments. 

Cardiologist heart

World’s first leadless LBBAP procedures linked to ‘promising’ outcomes

Cardiologists are turning to leadless pacemakers more and more for cardiac pacing, but those devices have not previously been able to perform LBBAP. This new analysis includes new data on the world’s very first leadless LBBAP procedures. 

tirzepatide injections Zepbound Eli Lilly

Tirzepatide bests semaglutide in patients with type 2 diabetes, kidney disease and heart failure

Researchers examined data from more than 9,000 patients, sharing their findings at SCAI 2025.

Philippe Genereux, MD, director of the structural heart program at Morristown Medical Center, principal investigator of the late-breaking EARLY TAVR trial, presented new data at ACC 2025 showing intervening earlier on patients with asymptomatic severe aortic stenosis leads to better outcomes.

Latest EARLY TAVR data suggest it is time to update industry guidelines

Philippe Genereux, MD, principal investigator of EARLY TAVR, presented new data at ACC.25 showing intervening early on crossover patients with asymptomatic severe aortic stenosis led to better outcomes and a reduced stroke rate. 

Thumbnail

Focal ablation yields lower treatment failure rates than surgery for prostate cancer

This is the first randomized controlled trial to compare the use of ultrasound energy-based focal ablation to robot-assisted radical prostatectomy.